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Abstract: 
The leader gene approach is a data mining method based on the systematic search for genes involved in a specific process and their ranking 
according to the number of interconnections with the other genes identified. The genes with the strongest interconnections are termed leader 
genes, since they may be supposed to play an important role in the process. The potential of malignant progression of OLP to oral squamous 
cell carcinoma (OSCC) is still not completely clear. In this study, the leader gene approach is applied to investigate the association between 
OLP and OSCC at a molecular level. Results were integrated with those obtained in an experimental analysis (see paper 1 of this series). 
Genes involved in OLP and OSCC were identified by systematic queries to dedicated databases. Interconnections among identified genes 
were calculated and given a confidence value using STRING database. Leader genes were identified by clustering genes according to their 
interconnections. This theoretical analysis shows that OLP and OSCC share two leader genes: TP53 and CDKN1A, involved in the PI3K 
signalling events mediated by AKT pathway. This finding and those obtained in the experimental analysis suggest the possible involvement 
of some key genes/proteins LCK, PIK3CA, BIRC5, TP53 and CDKN1A in the malignant progression from OLP to OSCC. Moreover, these 
findings support the role of some molecular pathways, namely IL2 signalling events mediated by PI3K, PI3K signalling events mediated by 
AKT, and, possibly, Aurora A signalling in the association between OLP and OSCC. 
 
Keywords: computational biology; gene interactions; genomics; oral lichen planus; oral carcinoma. 
 
Background: 
Oral lichen planus (OLP) is a T-cell-mediated chronic inflammatory 
oral mucosal disease of unknown etiology [1]. The histological 
lesions are characterized by a sub-epithelial inflammatory infiltrate, 
mainly constituted by T lymphocytes and focused to the basal 
keratinocytes [1]. OLP lesions are characterized by a higher degree 
of cell turnover than healthy tissue: the proliferation, the maturation 
and the apoptosis of basal keratinocytes require a fine regulation at 
a genomic level [2]. From these observations, OLP may be seen as a 
complex multifactorial disease [2]. The World Health Organization 
defined OLP as a premalignant condition, with a possible 
progression to oral squamous cell carcinoma (OSCC) [1, 2]. The 
progression from OLP to OSCC is a relatively rare event: although 
frequencies ranging from 0.4 to 6.5% have been reported, most 
studies suggest that the malignant progression rate is around 1% [2, 
3]. The molecular mechanisms determining the possible malignant 
development in OLP lesions are still not completely elucidated [3]. 
Further research is therefore advocated to clarify the molecular 
aspects of this potential relationship, including the identification of 
potential prognostic markers at a genomic and proteomic level [4].  
 
Bioinformatics and data-mining can play a central role in the 
analysis and interpretation of genomic and proteomic data [5, 6]. In 
particular, these disciplines may be useful to further clarify the 
pathophysiology of complex diseases, which are characterized by 
various biologic pathways, dependent upon the contribution of a 
large number of genes forming complex networks of interactions [5, 
6]. Interactions between genes may be direct (physical interactions 
between the proteins, confirmed by experimental techniques, such 
as NMR or crystallography) or indirect (involvement in the same 
metabolic pathway or co-expression in different conditions) [7].  
 
Recently, a data-mining method, defined as the “Leader Gene 
approach” have been proposed [5, 6]. This mining algorithm is 
based on the systematic search for the genes involved in a given 
process; the interaction among these genes are then calculated and 
genes are ranked according to the number and the confidence of all 
experimentally established interactions [5, 6], as derived from free 
Web-available databases, such as STRING (Search Tool for the 
Retrieval of Interacting Genes, Heidelberg, Germany) [7]. Genes in 
the highest rank are defined as ‘‘leader genes’’, since they can be 
preliminarily supposed to play an important role in the analyzed 
process [5, 6]. These genes may become potential targets for a 
targeted experimentation, which may be simpler than mass-scale 
molecular genomics and, at the same time, powerful [5, 6]. The 
Leader Gene approach was applied to different cellular processes 
and pathological conditions, such as the human T lymphocyte cell 
cycle, human kidney transplant and periodontitis [5, 6]; the results 
were integrated with a targeted experimental analysis, to draw an 
overall picture of these processes [8]. Recently, the Leader Gene 
approach was applied to infer the epidemiologically-established 
correlation between human periodontitis and type-2 diabetes [6]. 
Overall, the results showed that periodontitis and diabetes share four 
leader genes and that all leader genes are linked in a complex map 
of interactions. This finding may suggest an important role of leader 
genes in the association between these diseases; leader genes may 
be supposed, at least preliminarily, to act as hubs in the interaction 
map [5, 6]. Leader genes may therefore become promising targets 
for a dedicated experimentation. In this data-mining ab-initio study, 
we apply the leader gene approach to preliminarily investigate the 
molecular mechanisms underlying the potential association between 
OLP and OSCC. The theoretical results are integrated with some 
experimental findings, recently obtained by mean of 
immunohistochemistry and tissue micro-array on patient biopsies. 
 
Methodology: 
General architecture: 
The data mining algorithm followed is represented in Figure 1 [5, 
6]. First, a preliminarily set of genes with an established role in a 
specific process is identified by an iterative search of large-scale 
gene databases (PubMed, GeneBank, Geneatlas, Genecards), using 
several keyword-based searches and the official HGNC 
nomenclature. Second, the preliminary set of genes is expanded 
using the STRING database (version 8.2), excluding textmining-
derived interactions, to identify genes linked to those playing an 
established role in the process under study, and therefore potentially 
involved in it [7]. Only interactions with a confidence score >0.9, as 
given by STRING, are considered. Results are then filtered to 
discard false positives via a keyword-based query in PubMed, until 
no new genes are retrieved. Third, the interactions between all the 
genes identified are mapped using STRING. This database gives a 
combined association score to each gene-gene interaction, 
representing its strength. The combined association scores referring 
to each single gene are then summed to obtain a weighted number 
of links (WNL). Fourth, genes are clustered (hierarchical and K-
means algorithms) according to their WNL. The genes belonging to 
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the highest class are defined as leader genes. The other genes are 
defined as class B genes, class C genes, and so on. The differences 
in WNL among different classes are compared by ANOVA test 
(alpha value = 0.001). 
 
Leader genes in OLP and OSCC 
The above-described leader gene algorithm is applied to both OLP 
and OSCC. The resulting leader genes are compared. Research was 
last updated on 2th November 2009. Overall, 48 human genes were 
identified as involved or potentially involved in OLP; 7 of them 
were classified as leader genes (p<0.001 for their WNL vs other 
classes). In total, 208 human genes resulted as involved or 
potentially involved in OSCC; 5 of them were classified as leaders 
(p<0.001 for their WNL vs other classes). Table 1 (supplementary 
material) summarizes the established or putative role of all leader 
genes. OLP and OSCC share 2 leader genes: TP53 and CDKN1A. 
All leader genes involved in the control of cell cycle are closely 
interacting (Figure 2a). 
Pathways characterization and comparison with experimental 
data 
PI3K signalling pathway may play a role in the pathogenesis of 
OSCC [9]. The involvement of leader genes in this pathway has 
been checked in the Pathway Interaction Database (PID). Both 
shared leader genes and MDM2 are involved in PI3K signalling 
mediated by ATK1 pathway. The results of the data-mining process 
are compared and integrated, using STRING and PID databases, 
with the results of a recent experimental study, which identified 
LCK, PIK3CA and survivin (BIRC5) as potential biomarkers of the 
progression from OLP to OSCC. These genes are strongly 
interconnected with the two shared leader genes between OLP and 
OSCC, TP53 and CDKN1A (Figure 2b). The interactions seem to 
be mediated by AKT1 gene; three molecular pathways are involved 
in this network, namely (1) IL2 signalling events mediated by PI3K, 
(2) PI3K signalling events mediated by AKT, and (3) Aurora A 
signalling, including AURKA gene. 
 
Figure 1: Flow chart of the leader gene approach (reproduced from [6]). 
 
 
Figure 2: Maps of interactions, according to STRING software [7]. The lines connecting single genes represent physical interactions 
between proteins, confirmed by various experimental methods (magenta lines), correlation in gene expression experiments (dark blue) or the 
involvement in the same metabolic pathway (light blue). A) Interactions among leader genes in human oral lichen planus (OLP) and in 
human oral squamous cell carcinoma (OSCC). Leader genes in OLP involved in cell cycle regulation are circled in green; leader genes in 
OLP potentially determining cellular damage are circled in yellow. Leader genes in OSCC are circled in black. Leader genes shared between 
OLP and OSCC are circled in blue. B) Interactions among the leader genes (TP53 and CDKN1A) shared between OLP and OSCC and some 
key genes (LCK, PIK3CA and BIRC5) recently showed as playing a role in the malignant progression from OLP to OSCC. Molecular 
pathways and further genes (AKT1 and AURKA) linking the above-mentioned ones are also shown.  
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Discussion 
We applied the Leader Gene approach, a previously-validated data-
mining algorithm [5, 6, 8], to obtain a preliminary evaluation of the 
potential correlation between OLP and OSCC at a genomic level. 
Overall, two leader genes, i.e. those with the strongest 
interconnections among all genes involved in OLP or OSCC, were 
shared between these conditions: TP53 and CDKN1A. All the other 
leader genes involved in cell cycle were close interconnecting. 
These findings might suggest that leader genes may play an 
important role in the association between OLP and OSCC: even a 
small variation in the expression, in the sequence or in the 
regulation of these genes might have an impact on several other 
genes [8]. Moreover, the shared leader genes can be supposed, at 
least preliminarily, to act as hubs in the interaction map [5, 6]. 
Recently, the Leader Gene approach was applied to formulate new 
hypotheses on the correlation between periodontitis and diabetes: 
results showed that 4 leader genes were shared between the two 
diseases, while all the remaining leader genes were strongly linked 
[6]. In the present analysis, only two genes were linked; this may 
suggest, at least preliminarily, that the association between OLP and 
OSCC is weaker than that between periodontitis and diabetes. This 
hypothesis is in line with the rates of malignant progression from 
OLP to OSCC and those referring to periodontitis-diabetes 
comorbidity [2, 3, 6]. Data-mining was completely conducted ab-
initio [6]. A blind search might represent a proof of the validity of 
this approach, if the retrieved results are in line with current 
knowledge. After the ab-initio identification of leader genes, 
scientific literature was mined to verify the role of leader genes in 
OLP and OSCC. 
 
Evidence of the role of leader genes in OLP and in OSCC 
All the identified leader genes are actually playing a role in OLP or 
in OSCC. For instance, MMP2, TGFB1 and DCN are involved in 
cellular damage and their expression is increased in OLP lesions 
[10]. Similar findings were observed for CASP3 [11]; moreover, 
this gene and MDM2 are regulators of cell cycle and apoptosis, [12, 
13]. Leader genes in OSCC regulate cell cycle. A genome-wide 
profiling revealed the association of RB1 and BRCA1 with OSCC 
[14], while a reduced expression of CTNN1B in associated with 
aggressive OSCC [15]. TP53 and CDKN1A, the two shared leader 
genes, play a major role in the potential malignant progression. 
TP53 is associated to genome repair and pro-apoptotic signalling. 
An increase in TP53 expression is observed in OLP lesions [16]. 
Mutations in this gene are associated with progression to OSCC and 
the expression of TP53 protein correlates with poor prognosis in 
OSCC patients [16]. CDKN1A inhibition and misregulation 
frequently occur in OSCC [17]. 
 
Molecular pathways potentially involved between OLP and OSCC 
The potential association between impairment in the regulation of 
PI3K signalling pathway mediated by AKT1 and the pathogenesis 
of OSCC has been recently suggested [9]. Both TP53 and CDKN1A 
are involved in this pathway [18, 19], as well as another leader gene 
in OLP, MDM2 [20]. This finding may support the possible 
correlation between the two conditions. Recent findings, obtained in 
OLP and OSCC patients, have shown that the overexpression of 
three key proteins (LCK, PIK3CA and BIRC5) may be associated to 
an high risk of malignant progression (Oluwadara, paper 1 of this 
series). These proteins form a complex network of direct and 
experimentally-established interactions with TP53 and CDKN1A. 
Such network includes two other genes (AKT1 and AURKA) and 
three different pathways: the PI3K signalling pathway mediated by 
AKT1, the IL2 signalling events mediated by PI3K, and the Aurora 
A signalling. These pathways may play a role in the malignant 
progression from OLP to OSCC. For instance, it may be very 
preliminary suggested that an impairment in IL2 signalling, which 
promotes T-cell proliferation and subsequent continuous T-cell 
signalling and activation, may be associated to a reduction in 
immune activity and to an enhancement in the malignant potential 
of OLP lesions. 
 
Limitations: 
The present analysis presents several limitations. The first limitation 
is the lack of an experimental validation; however, like all data-
mining processes, the Leader Gene approach is only able to provide 
new well-grounded hypotheses, which may be either verified or 
discarded by a targeted experimentation, e.g. with microarrays or 
real-time polymerase chain reaction (RT-PCR) [5, 6]. Another 
limitation is the possible bias related to database mining [5, 6]. 
However, only strong and experimentally-established gene and 
protein interactions were considered [7]. These choices might limit, 
at least partially, a possible bias related to database mining.  
 
Conclusions: 
This analysis could further confirm that data-mining of existing 
databases may represent a starting point to improve our knowledge 
about cellular processes and diseases, to formulate new hypotheses 
and to plan targeted experimentation [5, 6]. In particular, the 
analysis of gene interaction maps and the ranking of genes 
according to their interconnections might help in identifying new 
targets for dedicated experimental analyses, which may confirm or 
discard each hypothesis and suggest potential risk factors and 
therapy targets [5, 6]. The results of this study must be interpreted 
together with the findings obtained in an experimental analysis 
conducted on a large number of biopsies from OLP and OSCC 
patients (Oluwadara, paper 1 of this series). Overall, these studies 
suggest the possible involvement of some key genes and of the 
encoded proteins (LCK, PIK3CA, BIRC5, TP53 and CDKN1A) in 
the malignant progression from OLP to OSCC. Moreover, these 
findings support the role of some molecular pathways, namely IL2 
signalling events mediated by PI3K, PI3K signalling events 
mediated by AKT, and, possibly, Aurora A signalling in the 
association between OLP and OSCC. Further details about these 
complex molecular networks will likely be provided by targeted 
DNA or protein microarrays, as previously suggested [4, 5, 6]. 
These analyses will be focused only on selected molecular targets 
and therefore will be much easier to interpret than mass-scale 
experiments. On this basis, further insights towards a better 
understanding of the molecular mechanisms underlying the 
potential progression from OLP to OSCC may be retrieved. 
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Supplementary material: 
 
Table 1: Leader genes in human oral lichen planus (OLP) and in human oral squamous cell carcinoma (OSCC) 
OLP OSCC 
Official 
Symbol 
Official Name Role Involvement 
in PI3K 
pathway 
Official 
Symbol 
Official Name Role Involvement 
in PI3K 
pathway 
TP53 tumor protein p53 Regulation 
of cell cycle 
 
Apoptotic 
signalling 
X TP53 tumor protein p53 Regulation 
of cell cycle 
 
Apoptotic 
signalling 
X 
DCN decorin Cellular 
damage 
 RB1 retinoblastoma 1 Regulation 
of cell cycle 
 
CASP3 caspase 3 Regulation 
of cell cycle 
 
Apoptotic 
signalling 
 
Cellular 
damage 
 CDKN1A cyclin-dependent 
kinase inhibitor 
1A (p21, Cip1) 
Regulation 
of cell cycle 
 
Apoptotic 
signalling 
X 
MMP2 matrix 
metallopeptidase 
Cellular 
damage 
 
 BRCA1 breast cancer 1, 
early onset 
Regulation 
of cell cycle 
 
 
TGFB1 transforming 
growth factor beta 1 
Cellular 
damage 
 
 CTNNB1 catenin (cadherin-
associated 
protein), beta 1, 
88kDa 
Regulation 
of cell cycle 
 
 
CDKN1A cyclin-dependent 
kinase inhibitor 1A 
(p21, Cip1) 
Regulation 
of cell cycle 
 
Apoptotic 
signalling 
X     
MDM2 Mdm2 p53 binding 
protein homolog 
(mouse) 
Regulation 
of cell cycle 
 
Apoptotic 
signalling 
X     
Shared leader genes are shown in bold type. Their role in OLP and, and the involvement in PI3K signalling events mediated by AKT, as 
derived from Protein Interaction Database is also shown 
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